Artiva Biotherapeutics, Inc. ARTV Increase Decrease In Operating Leaseright Of Useasset And Lease Liabilities
Increase Decrease In Operating Leaseright Of Useasset And Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept artv:IncreaseDecreaseInOperatingLeaserightOfUseassetAndLeaseLiabilities.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s increase decrease in operating leaseright of useasset and lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s increase decrease in operating leaseright of useasset and lease liabilities?
- Artiva Biotherapeutics, Inc. (ARTV) reported increase decrease in operating leaseright of useasset and lease liabilities of -$3K in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s increase decrease in operating leaseright of useasset and lease liabilities changed year-over-year?
- Artiva Biotherapeutics, Inc.'s increase decrease in operating leaseright of useasset and lease liabilities increased by 76.9% year-over-year, from -$13K to -$3K.
- What does increase decrease in operating leaseright of useasset and lease liabilities mean?
- Captures the net change in operating lease-related assets and liabilities that affects cash flow from operations, excluding cash payments. It reflects adjustments for lease modifications, terminations, or changes in lease terms that do not involve immediate cash outflows.